Effectiveness and Safety of Early Growth Hormone Treatment in Children Born Small for Gestational Age: Long-Term Data From NordiNet® International Outcome Study (IOS) and ANSWER Pr...

por Juul, Anders, Pietropoli, Alberto, Kelepouris, Nicky, Geffner, Mitchell E
Publicado 2021

THU008 Coverage Of Education And Training Of Traumatic Brain Injury-induced Growth Hormone Deficiency In US Endocrinology Fellowship Programs

por Ji Yuen, Kevin Choong, Adiga, Radhika, Kelepouris, Nicky, Cardenas, Javier
Publicado 2023

Thorough QT/QTc Study Evaluating the Effect of Macimorelin on Cardiac Safety Parameters in Healthy Participants

por Lissy, Michael, Demmel, Valentin, Sachse, Richard, Ammer, Nicola, Kelepouris, Nicky, Ostrow, Vlady
Publicado 2020

SAT-439 Impact on Health Care Resources: A Comparison of Costs Following Treatment with Pegvisomant and Somatostatin Analogues Using Optum Claims Database

por Kelepouris, Nicky, Emir, Birol, Loftus, Jane, Rubinstein, Emily, King, Donna, McDonald, Margaret
Publicado 2019

Outcomes in children treated with growth hormone for Prader-Willi syndrome: data from the ANSWER Program® and NordiNet® International Outcome Study

por Angulo, Moris, Abuzzahab, M. Jennifer, Pietropoli, Alberto, Ostrow, Vlady, Kelepouris, Nicky, Tauber, Maithe
Publicado 2020

Adult Growth Hormone Deficiency: Diagnostic and Treatment Journeys From the Patients’ Perspective

por Hoffman, Andrew R, Mathison, Tracy, Andrews, Deno, Murray, Kristine, Kelepouris, Nicky, Fleseriu, Maria
Publicado 2022

PMON60 Growth Hormone (GH) Replacement Therapy (GHRT) in Patients with Adult GH Deficiency (AGHD) Aged ≥60 Years: Data from NordiNet® IOS and the ANSWER Program

por Biller, Beverly, Gordon, Murray, Höybye, Charlotte, Olsen, Anne, Kelepouris, Nicky, Nedjatian, Navid, Weber, Matthias
Publicado 2022

Early Growth Hormone Initiation Leads to Favorable Long-Term Growth Outcomes in Children Born Small for Gestational Age

por Juul, Anders, Backeljauw, Philippe, Cappa, Marco, Pietropoli, Alberto, Kelepouris, Nicky, Linglart, Agnès, Pfäffle, Roland, Geffner, Mitchell
Publicado 2022

Cardiovascular safety of growth hormone treatment in Noonan syndrome: real-world evidence

por Romano, Alicia, Kaski, Juan Pablo, Dahlgren, Jovanna, Kelepouris, Nicky, Pietropoli, Alberto, Rohrer, Tilman R, Polak, Michel
Publicado 2021

Outcomes in growth hormone-treated Noonan syndrome children: impact of PTPN11 mutation status

por Jorge, Alexander A L, Edouard, Thomas, Maghnie, Mohamad, Pietropoli, Alberto, Kelepouris, Nicky, Romano, Alicia, Zenker, Martin, Horikawa, Reiko
Publicado 2022

SAT-444 Pituitary Function and the Response to GH Replacement Therapy in Patients with Histiocytosis: Analysis of the Pfizer International Metabolic Database (KIMS)

por Touraine, Philippe, Mattsson, Anders, Burman, Pia, Van Beek, Andre, Aydin, Ferah, Kelepouris, Nicky, Feldt-Rasmussen, Ulla, Camacho-Hubner, Cecilia
Publicado 2019

Factors Associated With Response to Growth Hormone in Pediatric Growth Disorders: Results of a 5-year Registry Analysis

por Ross, Judith, Fridman, Moshe, Kelepouris, Nicky, Murray, Kristine, Krone, Nils, Polak, Michel, Rohrer, Tilman R, Pietropoli, Alberto, Lawrence, Neil, Backeljauw, Philippe
Publicado 2023

Pregnancy outcomes in women receiving growth hormone replacement therapy enrolled in the NordiNet® International Outcome Study (IOS) and the American Norditropin® Studies: Web-Enab...

por Biller, Beverly M. K., Höybye, Charlotte, Carroll, Paul, Gordon, Murray B., Birkegård, Anna Camilla, Kelepouris, Nicky, Nedjatian, Navid, Weber, Matthias M.
Publicado 2021

Long-term Effectiveness and Safety of GH Replacement Therapy in Adults ≥60 Years: Data From NordiNet® IOS and ANSWER

por Biller, Beverly M K, Höybye, Charlotte, Ferran, Jean-Marc, Kelepouris, Nicky, Nedjatian, Navid, Olsen, Anne Helene, Weber, Matthias M, Gordon, Murray B
Publicado 2023

Reduced CV risk with long-term GH replacement in AGHD: data from two large observational studies

por Höybye, Charlotte, Biller, Beverly M K, Ferran, Jean-Marc, Gordon, Murray B, Kelepouris, Nicky, Nedjatian, Navid, Olsen, Anne H, Weber, Matthias M
Publicado 2022

Early GH Treatment Is Effective and Well Tolerated in Children With Turner Syndrome: NordiNet(®) IOS and Answer Program

por Backeljauw, Philippe, Blair, Joanne C, Ferran, Jean-Marc, Kelepouris, Nicky, Miller, Bradley S, Pietropoli, Alberto, Polak, Michel, Sävendahl, Lars, Verlinde, Franciska, Rohrer, Tilman R
Publicado 2023

Long-Term Safety of Growth Hormone Treatment in Childhood: Two Large Observational Studies: NordiNet IOS and ANSWER

por Sävendahl, Lars, Polak, Michel, Backeljauw, Philippe, Blair, Joanne C, Miller, Bradley S, Rohrer, Tilman R, Hokken-Koelega, Anita, Pietropoli, Alberto, Kelepouris, Nicky, Ross, Judith
Publicado 2021

Development of a Novel Algorithm to Identify People with High Likelihood of Adult Growth Hormone Deficiency in a US Healthcare Claims Database

por Yuen, Kevin C. J., Birkegard, Anna Camilla, Blevins, Lewis S., Clemmons, David R., Hoffman, Andrew R., Kelepouris, Nicky, Kerr, Janice M., Tarp, Jens M., Fleseriu, Maria
Publicado 2022

LBMON197 Predictors Of Response To Growth Hormone Treatment In Pediatric Growth Disorders: Analysis From The Answer Program And Nordinet® IOS

por Ross, Judith L, Fridman, Moshe, Kelepouris, Nicky, Murray, Kristine, Krone, Nils Peter, Polak, Michel, Nedjatian, Navid, Rohrer, Tilman Robert, Pietropoli, Alberto, Lawrence, Neil, Backeljauw, Philippe Ferdinand
Publicado 2022

SAT-LB11 Adult Growth Hormone Deficiency Transition Care From Pediatric to Adult Services: Insights From a US Advisory Board

por Yuen, Kevin C J, Alter, Craig A, Miller, Bradley Scott, Gannon, Anthony W, Tritos, Nicholas A, Samson, Susan Leanne, Dobri, Georgiana Alina, Kurtz, Kristine, Strobl, Frank, Kelepouris, Nicky
Publicado 2020